Table 2.
Patient | 28 | ||
Gender: Male/Female | 12/16 | ||
Age: mean (range) |
53 (18–79) |
||
Laboratory results |
Mean (range) |
Normal range of value |
Number of patients with value outside the range |
AST | 35 (12–290) | 5–42 U/L | 1 |
ALT | 30 (8–192) | 10–40 U/L | 4 |
ALP | 266 (30–1895) | 40–129 U/L | 12 |
GGT | 105 (20–530) | 5–85 U/L | 10 |
LDH | 365 (153–658) | 135–250 U/L | 21 |
Total Bilirubin | 1.06 (0.2–14) | 0.2–1 mg/dL | 4 |
Direct Bilirubin | 0.74 (0.01–13.39) | 0–0.3 mg/dL | 4 |
Total Protein | 7.64 (6.3–8.7) | 6.4–8.3 g/dL | 5 |
AFP | 7.78 (0.9–94.55) | <13.6 ng/mL | 1 |
CEA | 2.06 (0.23–6.19) | <5 ng/mL | 1 |
CA 19-9 | 18.6 (2.3–73) | 0–34 U/mL | 1 |
AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, ALP: Alkaline phosphatase, GGT: Gamma-glutamyl transpeptidase, LDH: Lactate dehydrogenase, AFP: Alpha-fetoprotein, CEA: Carcinoembryonic antigen, CA 19-9: Cancer antigen 19-9.